PubMed · 10243103
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M J Ball, S Raymond. 1979. Lab computers: will performance replace promise?. https://pubmed.ncbi.nlm.nih.gov/10243103/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
BACKGROUND: Present methods for measuring serum total iron-binding capacity (TIBC) involve manipulation of samples or performance of two assays on each sample. We developed a direct automated assay (DTIBC) for TIBC. METHODS: We added to serum a saturating amount of iron bound to an excess of chelating dye at a low pH, recorded a blank reading that represented the sum of the saturating amount of iron plus the serum iron, and then added a strong neutral pH buffer. The decrease in absorbance (as transferrin extracts iron from the iron-dye complex) is directly proportional to the TIBC. TIBC values for 125 patients were determined by DTIBC, alumina column TIBC (AC), magnetic particle TIBC (MTIBC), and the UIBC method (UIBC) on Roche COBAS FARA and Mira chemistry analyzers. In a separate study, TIBC values for 128 patients were determined on an Olympus AU400 by the DTIBC and the MTIBC methods. RESULTS: Methods comparisons on the COBAS analyzers yielded the following results: DTIBC = 1.05(MTIBC) - 1.0 micromol/L (r = 0.987; S(y/x) = 2.6 micromol/L); DTIBC = 1.07(AC) - 1.0 micromol/L (r = 0.982; S(y/x) = 3.0 micromol/L); and DTIBC = 1.14(UIBC) + 3.4 micromol/L (r = 0.982; S(y/x) = 3.0 micromol/L). A similar correlation study using the Olympus AU400 yielded DTIBC = 1.00(MTIBC) - 0.1 micromol/L (r = 0.983; S(y/x) = 2.7 micromol/L). The assay was linear from 12.5 to 125 micromol/L (70-700 microg/dL) TIBC on the COBAS FARA. Within- and between-run imprecision (CV) was <or=4.8% at two concentrations. Plasma samples were unsuitable for the method. No interference was seen with common interferants other than ascorbate, deferoxamine, and ferrous sulfate, and only at concentrations well above normal. CONCLUSION: The new DTIBC assay is suitable for routine use in clinical laboratories and may improve the quality of iron metabolism studies.
Within the frame of inprocess analytics of the synthesis of pharmaceutical drugs a lot of HPLC methods are required for checking the quality of intermediates and drug substances. The methods have to be developed in terms of optimal selectivity and low limit of detection, minimum running time and chromatographic robustness. The goal was to shorten the method development process. Therefore, the screening of stationary phases was automated by means of switching modules equipped with 12 HPLC columns. Mobile phase and temperature could be optimized by using Drylab after evaluating chromatograms of gradient elutions performed automatically. The column switching module was applied for more than three dozens of substances, e.g. steroidal intermediates. Resolution (especially of isomeres), peak shape and number of peaks turned out to be the criteria for selection of the appropriate stationary phase. On the basis of the "best" column the composition of the "best" eluent was usually defined rapidly and with less effort. This approach leads to savings in manpower by more than one third. Overnight, impurity profiles of the intermediates were obtained yielding robust HPLC methods with high selectivity and minimized elution time.
The negative interference of conjugated, unconjugated, and delta bilirubin on patient serum creatinine determined by the kinetic Jaffe reaction is the unresolved problem. We compared bilirubin interference on thirty patients' serum creatinine obtained from four analyzers, with and without deprotenization before the Jaffe reaction, to the Vitros dry enzymatic method. We found significant negative interference from bilirubin on serum creatinine in all samples directly applied to four wet chemical methods, except the one incorporated with serum blank rate. The negative interferences linearly related to bilirubin concentration. However, bilirubin did not interfere on serum creatinine obtained from all wet chemical methods incorporated with deproteinization process before the reaction. We conclude that deproteinized serum before the reaction is the best approach to eliminate all forms of bilirubin interference on serum creatinine determined by the kinetic Jaffe reaction.